Posted on February 24, 20232/24/23
The Promise and Peril of ChatGPT in Healthcare and Pharma Marketing
Posted on February 22, 20232/22/23
Q and A With Greg Skalicky, president and chief revenue officer of EVERSANA
Posted on February 17, 20232/17/23
Can ChatGPT revolutionize pharma marketing?
Posted on February 16, 20232/16/23
The Explosive Arrival of Chat GPT and Generative AI
Posted on February 9, 20232/9/23
Disruptive Factors Shape RA Landscape
Posted on February 9, 20232/9/23
Inside the Pharma Name Game: Drug Word Choice Key to Building a Lasting Identity
Posted on February 8, 20232/8/23
MM+M Podcast 2.8.23: Eisai’s pricing transparency, GAO’s report on ‘gain-of-function’ research and MrBeast’s polarizing video
Posted on February 7, 20232/7/23
ChatGPT and generative AI land in pharma marketing with sense of awe — and plenty of caution
Posted on February 1, 20232/1/23
2023 Pharma Choice App Gold Winner EVERSANA INTOUCH and The Chrysalis Initiative
Posted on February 1, 20232/1/23